[{"Assets_0_Q2_USD":355706000.0,"CommonStockSharesOutstanding_0_Q2_shares":289918978.0,"NetIncomeLoss_2_Q2_USD":-88319000.0,"NetIncomeLoss_1_Q2_USD":-44465000.0,"StockholdersEquity_0_Q2_USD":-59062000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]